abstract |
The present invention relates to the compound (¿) -1,3-diphenyl-2-benzyl-1-hydroxy-3-propanone, a dibenzoylmethane derivative, and the formulation comprising this compound. Such a compound and formulation are active for melanoma-type cancer cells and may be used by the pharmaceutical industry to produce medicines and cosmetics for treating people with this type of pathology. |